Accession Number:

AD0662325

Title:

ALTERATIONS OF MONOAMINE CONTENT BY DECABORANE AFTER MONOAMINE OXIDASE INHIBITION BY IPRONIAZID.

Descriptive Note:

Rept. for Jun 65-Jun 66,

Corporate Author:

SCHOOL OF AEROSPACE MEDICINE BROOKS AFB TEX

Report Date:

1967-08-01

Pagination or Media Count:

11.0

Abstract:

Pretreatment of rats with 100 mg. iproniazidkg. does not prevent the fall of brain and heart norepinephrine content produced by the subsequent injection of 15 mg. decaborane B10H14kg. This phenomenon is in contrast to the effect of the drug combination on rat brain 5-hydroxytryptamine. In this case, pretreatment with iproniazid does prevent the decaborane-mediated decline of brain 5-hydroxytryptamine. The results are discussed in relation to the mechanism of action of decaborane. Author

Subject Categories:

  • Anatomy and Physiology
  • Pharmacology

Distribution Statement:

APPROVED FOR PUBLIC RELEASE